SAK3
CAS No. 1256269-87-0
SAK3( T-VGCC enhancer SAK3 )
Catalog No. M11047 CAS No. 1256269-87-0
SAK3 (T-VGCC enhancer SAK3) is a potent, orally acitve enhancer of T-type voltage-gated Ca2+ channel (T-VGCC).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 293 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSAK3
-
NoteResearch use only, not for human use.
-
Brief DescriptionSAK3 (T-VGCC enhancer SAK3) is a potent, orally acitve enhancer of T-type voltage-gated Ca2+ channel (T-VGCC).
-
DescriptionSAK3 (T-VGCC enhancer SAK3) is a potent, orally acitve enhancer of T-type voltage-gated Ca2+ channel (T-VGCC), enhances CaV3.1 and CaV3.3, but not CaV3.2 activity at concentrations of 0.01-10 nM in neuro2A cells in vitro; significantly enhanced acetylcholine (ACh) release in the hippocampal CA1 region of na?ve mice (0.5 mg/kg, p.o.); significantly enhanced hippocampal ACh levels in olfactory-bulbectomized (OBX) mice, rescuing impaired memory-related behaviors.
-
In VitroSAK3 (0.01-10 nM) significantly enhances Cav3.1 or Cav3.3 currents in neuro2A cells ectopically expressing Cav3.1 or Cav3.3, respectively. Cell Viability AssayCell Line:Cav3.1 or Cav3.3-overexpressing neuro2A cells Concentration:0.1 nM Incubation Time:270 sResult:Rapidly increased Ca2+ currents
-
In VivoAcute SAK3 (0.5 mg/kg) oral administration promotes acetylcholine (ACh) release in hippocampal CA1 via T-VGCC stimulation via enhancing T-type Ca2+ channel. Animal Model:Animal Model:Cav3.1 knockout (KO) miceDosage: 0.5 mg/kg Administration:Administered p.o.Result:Significantly increased ACh release in CA1, peaking at 20 min after oral administration.
-
SynonymsT-VGCC enhancer SAK3
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1256269-87-0
-
Formula Weight369.421
-
Molecular FormulaC20H23N3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=C(N2CCCCC2)C3(N4C=CC=C(C)C4=NC3=O)CC1=O)OCC
-
Chemical NameEthyl 8'-methyl-2',4-dioxo-2-(piperidin-1-yl)-2'H-spiro[cyclopent[2]ene-1,3'-imidazo[1,2-a]pyridine]-3-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yabuki Y, et al. Neuropharmacology. 2017 May 1;117:1-13.
2. Izumi H, et al. Neuroscience. 2018 May 1;377:87-97.
3. Husain N, et al. Pharmacology. 2018;101(5-6):309-321.
4. Wang S, et al. PLoS One. 2018 Dec 20;13(12):e0206986.
molnova catalog
related products
-
Iganidipine
Iganidipine(NKY 722) is a new water-soluble Ca2+ antagonist with antihypertensive activity for research and neurological related diseases.
-
Oxodipine
Oxodipine, a dihydropyridine-type calcium antagonist, inhibited KCl-induced aortic contraction in rabbits and reduced cardiac force in less potent rat ventricular test-paper contractions.
-
(S)-crizotinib
(S)-crizotinib(IC50 of 72 nM), an effective MTH1 (NUDT1) inhibitor, is the (S)-enantiomer of crizotinib.
Cart
sales@molnova.com